Aalborg, North Denmark Region, Denmark LD Pensions appeared to be the Corporate Investor, which was created in 1970. The venture was found in Europe in Denmark. The main department of described Corporate Investor is located in the Aalborg.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the LD Pensions, startups are often financed by SLS Venture, Index Ventures, Dansk Innovation. The meaningful sponsors for the fund in investment in the same round are SLS Venture, Novo Holdings, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by SLS Venture, SR One, Oxford Bioscience Partners.
When the investment is from LD Pensions the average startup value is 50-100 millions dollars. The high activity for fund was in 2006. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this Corporate Investor is 3 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this LD Pensions performs on 6 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year.
The fund has exact preference in some founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline AdvanDx, 7TM Pharma, NsGene Among the most popular fund investment industries, there are Medical, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - Denmark. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Funds with similar focus
| Fund Name | Location |
| Adverline | France, Ile-de-France, Paris |
| Anchor Capital | New York, New York, United States |
| Biotech Insight Ventures | California, Pebble Beach, United States |
| CME Ventures | - |
| EDBV Management | Central, Central Region, Singapore |
| Grants4Apps Turkey | - |
| Hillman Medical Ventures | - |
| HMW Capital | Canada, Ontario, Toronto |
| Huhui Touzi | China, Guangdong Province, Luohu District |
| ITIC: Industrial Technology Investment Corporation | Taipei, Taiwan |
| Liquid Ventures | California, Marina Del Rey, United States |
| Prairie Angels | Chicago, Illinois, United States |
| R.J. Steichen & Co. | - |
| Rockwell Automation | Albertslund, Capital Region of Denmark, Denmark |
| Stanley Black & Decker | Connecticut, New Britain, United States |
| Suncrest Investment | China, Guangdong, Shenzhen |
| True Wind Capital Management | California, San Francisco, United States |
| Washington Federal | Seattle, United States, Washington |
| Xinxinhehe Investment Enterprise of Lhasa Economic and Technological Development Zone | Chengguan District, China, Lhasa |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AdvanDx | $8M | 12 Oct 2009 | Woburn, Massachusetts, United States | ||
AdvanDx | $15M | 18 Sep 2007 | Woburn, Massachusetts, United States | ||
AdvanDx | $5M | 08 May 2006 | Woburn, Massachusetts, United States | ||
7TM Pharma | $22M | 31 Mar 2006 | Denmark, " Denmark"} | ||
Symphogen | $25M | 05 Nov 2004 | Capital Region of Denmark | ||
AdvanDx | $5M | 24 Nov 2003 | Woburn, Massachusetts, United States | ||
T-cellic | $6M | 07 Nov 2003 | Capital Region of Denmark | ||
ACADIA Pharmaceuticals | $3M | 13 Aug 1997 | San Diego, California, United States | ||
ACADIA Pharmaceuticals | $6M | 04 Feb 1997 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AdvanDx | $8M | 12 Oct 2009 | Woburn, Massachusetts, United States | ||
AdvanDx | $15M | 18 Sep 2007 | Woburn, Massachusetts, United States | ||
AdvanDx | $5M | 08 May 2006 | Woburn, Massachusetts, United States | ||
7TM Pharma | $22M | 31 Mar 2006 | Denmark, " Denmark"} | ||
Symphogen | $25M | 05 Nov 2004 | Capital Region of Denmark | ||
AdvanDx | $5M | 24 Nov 2003 | Woburn, Massachusetts, United States | ||
T-cellic | $6M | 07 Nov 2003 | Capital Region of Denmark | ||
ACADIA Pharmaceuticals | $3M | 13 Aug 1997 | San Diego, California, United States | ||
ACADIA Pharmaceuticals | $6M | 04 Feb 1997 | San Diego, California, United States |
